Abstract
The incidence of brain radiation necrosis is increasing in NSCLC patients undergoing radiotherapy for brain metastases. • [11C] methionine–PET and MRS are valuable tools for diagnosing brain radiation necrosis. • Bevacizumab is an effective treatment for brain radiation necrosis in patients with nonsquamous NSCLC.
Original language | English |
---|---|
Pages (from-to) | 581-586.e3 |
Journal | Clinical Lung Cancer |
Volume | 25 |
Issue number | 6 |
DOIs | |
Publication status | Published - Sept 2024 |
All Science Journal Classification (ASJC) codes
- Oncology
- Pulmonary and Respiratory Medicine
- Cancer Research